Stockreport

Why The PAVmed (PAVM) Story Is Shifting After A Major Valuation Reset [Yahoo! Finance]

PAVmed Inc.  (PAVM) 
US:NASDAQ Investor Relations: ir.pavm.com
PDF PAVmed is back in focus after analysts reset their fair value estimate from US$263.00 to US$40.50, a major shift that puts a very different marker on what they see as r [Read more]